Craft

BioSig Technologies

Stock Price

$1

2024-10-29

Market Capitalization

$16.3 M

2024-10-29

Revenue

$200 K

FY, 2025

BioSig Technologies Summary

Company Summary

Overview
BioSig Technologies is a medical device company developing a biomedical signal processing technology for the electrophysiology market. It offers the PURE EP System, a surface electrocardiogram (ECG) and intracardiac multichannel analysis system providing cardiac signal recordings to help electrophysiologists identify appropriate catheter ablation targets.
Type
Public
Status
Active
Founded
2009
HQ
Westport, CT, US | view all locations
Website
https://www.biosig.com/
Cybersecurity rating
ESG rating
40-49 out of 100|View all ESG data
Sectors

Key People

  • Kenneth L. Londoner

    Kenneth L. Londoner, Founder, Chief Executive Officer, Chairman, and Director

    • Andrew Ballou

      Andrew Ballou, Vice President, Investor Relations

      • David Weild

        David Weild, Director

        • Donald E. Foley

          Donald E. Foley, Director

          LocationsView all

          2 locations detected

          • Westport, CT HQ

            United States

            54 Wilton Rd 2nd floor

          • Los Angeles, CA

            United States

            12424 Wilshire Blvd #745

          BioSig Technologies Financials

          Summary Financials

          Net income (Q1, 2026)
          ($46.7M)
          Cash (Q1, 2026)
          $6.9M
          EBIT (Q1, 2026)
          ($35.7M)

          Footer menu